GlaxoSmithKline's consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the drugmaker. The name of the ...

GSK plc announced an update regarding its total voting rights and capital for shareholders, as required by the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. As of December ...

Unlike its rival, GSK had failed to develop a timely Covid-19 shot. Its share performance lagged. Walmsley, who was promoted ...

In July 2022, GSK de-merged its Consumer Healthcare segment into a standalone company. The independent Consumer Healthcare company was named Haleon HLN. GSK is witnessing increased sales growth in ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

The global healthcare company ... Unilever said in a statement the GSK consumer arm "would be a strong strategic fit as Unilever continues to reshape its portfolio". The consumer goods giant ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a price target of ...

ICICI Direct recommended hold rating on GSK Consumer with a target price of ... of Boost and Horlicks will see lower volume growth in health food drinks and earnings growth over three years ...

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

GSK CEO Emma Walmsley's bet on Arexvy has hit a snag in recent months after the U.S. public health agency narrowed the age recommendation for use of RSV vaccines and delayed the recommendation for ...

GSK has drawn on a vast bank of images and conversations from key global markets to help it establish a series of evolving “Health & Wellness Codes”. As GSK prepares to separate its pharma and ...